Progress Or Hype? Looking At A Decade Of Cell Therapy In Japan

Regulatory Approach Evolving After Challenges

 
• By Lisa Takagi
  
After ten years of promising investment for cell therapy, Japan has cautiously reviewing its policies.
After a decade of supportive regulations for cell therapies, Japan is reviewing some policies • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia